10.50
+0.50
+(5.00%)
At close: April 17 at 3:57:21 PM GMT+1
Breakdown
4/30/2024
4/30/2023
4/30/2022
4/30/2021
Total Assets
23,576
26,855
35,106
49,058
Total Liabilities Net Minority Interest
27,081
36,503
33,712
40,370
Total Equity Gross Minority Interest
-3,505
-9,648
1,394
8,688
Total Capitalization
13,861
7,240
17,831
23,807
Common Stock Equity
-3,505
-9,648
1,394
8,688
Capital Lease Obligations
894
1,052
1,171
271
Net Tangible Assets
-3,505
-9,648
1,394
5,273
Working Capital
15,478
16,637
25,713
42,373
Invested Capital
15,467
8,833
19,251
23,807
Tangible Book Value
-3,505
-9,648
1,394
5,273
Total Debt
19,866
19,533
19,028
15,390
Net Debt
4,155
--
--
--
Share Issued
928,979.98
819,221.48
815,535.42
815,535.42
Ordinary Shares Number
928,979.98
819,221.48
815,535.42
815,535.42
4/30/2021 - 2/12/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OXB.L Oxford Biomedica plc
299.00
-1.64%
SAR.L Sareum Holdings plc
17.50
-5.41%
PRTCl.XC
OBD.L Oxford BioDynamics Plc
0.4500
0.00%
IMM.L ImmuPharma plc
2.5750
+0.98%
PRTC.L PureTech Health plc
123.40
+0.82%
TRX.L Tissue Regenix Group plc
36.50
0.00%
OSE.PA OSE Immunotherapeutics SA
5.90
-1.01%
POLB.L Poolbeg Pharma PLC
2.7000
0.00%
SBTX.L SkinBioTherapeutics plc
21.25
+6.25%